Acute Coronary Syndrome

Twenty-three hospitals from across Arkansas have joined the Arkansas Heart Attack Registry (AHAR),…
Biopharmaceutical company Amarin this week announced the topline results of its REDUCE-IT trial, a…
Mitral valve prolapse (MVP)—a common condition that’s rarely serious—might boost heart patients’…
A novel, polymer-free amphilius-eluting stent known as the “Cre8” was proven noninferior to the…
Resolute Onyx, a polymer-coated zotarolimus-eluting stent, has been proven safe and effective in an…
The proportion of percutaneous coronary interventions (PCIs) performed in nonagenarians has more…
Despite having the highest burden of cardiovascular disease in the U.S. and averaging more…
The prevalence of acute myocardial infarction (AMI) in the heart transplant (HT) population is “…
ST-segment elevation myocardial infarction (STEMI) patients have better odds of survival if…
Despite overall advances in healthcare and targeted initiatives to address disparities in care,…
Visual estimations of the completeness of revascularization failed to predict subsequent…
Cerner and Duke Clinical Research Institute have teamed up to develop a new CVD risk calculator app…